North Suffolk Mental Health Association

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, North Suffolk Mental Health Association sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials none currently recruiting 10 completed later-stage tilt top decile by trial count

North Suffolk Mental Health Association: 11 sponsored US clinical trials, none currently recruiting.

North Suffolk Mental Health Association sponsors 11 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 10 completed. 7 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Schizophrenia, with 3 trials.

Top-decile sponsor footprint

North Suffolk Mental Health Association ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 67/100

10 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

11 total, page 1 of 1

COMPLETED NA

A Comparison of Two Cognitive Batteries in People With Schizophrenia

NCT00499044
TERMINATED Phase 1

Study of the Effects of Glycine on Symptoms and Memory in Patients With Schizophrenia

NCT00575848
COMPLETED Phase 4

Smoking Relapse Prevention in Schizophrenia

NCT00320697
COMPLETED

Disturbances of Kynurenine Pathway of Trytophan Metabolism in Schizophrenia: A Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR) Study

NCT00573300
COMPLETED Phase 4

A Placebo-Controlled, Cross-Over Trial of Aripiprazole

NCT00351936
COMPLETED Phase 4

The Effects of Nicotine Withdrawal on Reward Responsivity in Schizophrenia

NCT00373126
COMPLETED Phase 4

Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus

NCT00351000
COMPLETED Phase 4

Galantamine for Cognition in People With Schizophrenia

NCT00320736
COMPLETED Phase 4

A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia

NCT00573417
COMPLETED Phase 2

Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia

NCT00235352
COMPLETED Phase 4

Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia

NCT00320723

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 4 7

Therapeutic Areas

Schizophrenia 3
Schizoaffective Disorder 2

How the North Suffolk Mental Health Association archive is shaped

11 indexed studies, none listed as recruiting (0% open); 10 completed (91%).

Phase mix: 7 late (III/IV) vs 2 early (I/II) (later-stage heavy).

Top condition: Schizophrenia (3 trials), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

North Suffolk Mental Health Association: archived-pipeline peers nationwide

Peers matched on 11 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

North Suffolk Mental Health Association sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share North Suffolk Mental Health AssociationAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiome10xBio22nd Century Group23andMe3-C Institute for Social Development
North Suffolk Mental Health Association sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

North Suffolk Mental Health Association sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this North Suffolk Mental Health Association page

11 registered trials is a research-attention snapshot, not an endorsement of North Suffolk Mental Health Association or any single study.

  • None of North Suffolk Mental Health Association's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Schizophrenia is the condition North Suffolk Mental Health Association studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Schizophrenia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

North Suffolk Mental Health Association pipeline card: 11 registered trials from official public datasets.Report a data error.